BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15996650)

  • 1. Complement activation and diabetic vascular complications.
    Østergaard J; Hansen TK; Thiel S; Flyvbjerg A
    Clin Chim Acta; 2005 Nov; 361(1-2):10-9. PubMed ID: 15996650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-binding lectin (MBL) and vascular complications in diabetes.
    Hansen TK
    Horm Metab Res; 2005 Apr; 37 Suppl 1():95-8. PubMed ID: 15918118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and cardiovascular disease.
    Bjerre M; Hansen TK; Flyvbjerg A
    Horm Metab Res; 2008 Sep; 40(9):626-34. PubMed ID: 18792874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for diabetic nephropathy.
    Bruno S; Cattaneo D; Perico N; Remuzzi G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):747-71. PubMed ID: 16262561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of macrophages in complications of type 2 diabetes.
    Tesch GH
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1016-9. PubMed ID: 17714088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily.
    Flyvbjerg A
    Nat Rev Endocrinol; 2010 Feb; 6(2):94-101. PubMed ID: 20098449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and the role of erythropoietin in diabetes.
    McGill JB; Bell DS
    J Diabetes Complications; 2006; 20(4):262-72. PubMed ID: 16798479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The marriage of glucose and blood vessels: it isn't all that sweet.
    Xiong WC; Stern DM
    Cell Metab; 2005 Oct; 2(4):212-5. PubMed ID: 16213223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of growth factors in diabetic kidney disease.
    Chiarelli F; Gaspari S; Marcovecchio ML
    Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in diabetic nephropathy.
    Zent R; Pozzi A
    Semin Nephrol; 2007 Mar; 27(2):161-71. PubMed ID: 17418685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating nucleic acids and diabetic complications.
    Butt AN; Shalchi Z; Hamaoui K; Samadhan A; Powrie J; Smith S; Janikoun S; Swaminathan R
    Ann N Y Acad Sci; 2006 Sep; 1075():258-70. PubMed ID: 17108219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic retinopathy and systemic vascular complications.
    Cheung N; Wong TY
    Prog Retin Eye Res; 2008 Mar; 27(2):161-76. PubMed ID: 18249026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.